Clinical Trials and Practice Open Journal

Editorial Board

Clinical Trials and Practice - Open Journal


Li Ming Wen, MD, MMed, PhD

Clinical Associate Professor
School of Public Health
Sydney Medical School, University of Sydney
Shanghai 10th Peoples Hospital
Faculty of Medicine, University of Tongji
Shanghai, China

Professor Li Ming Wen is graduated from the Second Military Medical University (SMMU), Shanghai, China. After migrating to Australia, in 1994, He obtained Master of Medicine and PhD degrees from Sydney Medical School, the University of Sydney. He has published over 80 peer reviewed papers in high impact journals including Lancet, BMJ, JAMA Pediatrics and IJO. He has been a Research and Evaluation Manager in the Health Promotion Service of Sydney Local Health District, NSW Health, Australia, since 2000. In this role he is also affiliated with Shanghai 10th Peoples Hospital, Faculty of Medicine, University of Tongji, and Sydney Medical School, University of Sydney.
Prof. Wen was the lead author of a paper titled “Driving to work is associated with overweight and obesity: Findings from the 2003 New South Wales Health Survey” published in International Journal of Obesity in 2006. The study was one of few studies linking car use and overweight and obesity for the first time. He was an invited Lead Guest Editor for the Journal of Environmental and Public Health on the Special issue on the effect of active transport, transport systems and urban design on environmental and population health, which has now been published ( Currently, he is an invited Lead Guest Editor for the Journal of Obesity for a special Issue on The Effect of Early Life Factors and Early Interventions on Childhood Overweight and Obesity.
Prof. Wen is a Principal Investigator (PI) of the Healthy Beginnings Trial, a home-based early obesity intervention, funded by NHMRC (National Health and Medical Research Council) for 2008-2014. Internationally, the study was the first randomized controlled trial of a home-based early childhood obesity intervention in the first two years of life. This unique intervention program, aimed at tacking childhood obesity in the beginning of life, was delivered by nurses to 667 first –time mothers in their homes. Each family received 8 visits in the first two years of their childs life. Nurses provided advice to mothers around infant feeding practices, child and family eating, as well as child play and TV viewing time. The results show that the approach taken by the Healthy Beginnings Program is promising in significantly reducing a childs Body Mass Index and developing healthy eating and lifestyle habits, with significant improvements in vegetable consumption and reduction in television viewing times. The main results of the trial were published in the BMJ (BMJ 2012; 344: e3732). The sustainability assessment and economic evaluation of the Healthy Beginnings Program are currently underway and will be completed by late 2015. With his ground-breaking and novel work, Prof. Wen is internationally recognized as a leader in early life interventions to prevent obesity. More information about Healthy Beginnings Program can be found at

               Associate Editors

Bolaji Egbewale, PhD

Senior Lecturer in Biostatistics
Department of Community Medicine
Ladoke Akintola University of Technology
Ogbomosho, Nigeria

Dr. Egbewale is a Senior Lecturer in Biostatistics in the Department of Community Medicine, Ladoke Akintola University of Technology, (LAUTECH) Ogbomoso, Nigeria where he teaches modules in Medical statistics and Research methodology across a wide range of undergraduate and post graduate programmes. He has supervised several undergraduate and postgraduate students, authored and co-authored many research articles that are already published in peer-review medical journals. He obtained his PhD degree in Biostatistics from the University of Keele, United Kingdom.

Surendra Rajpurohit, PhD

Assistant Research Scientist
Department of Biochemistry and Molecular Biology
Cancer Research Center
Medical College of Georgia (AU)
1410 Laney Walker Blvd, CN 3116A
Augusta, Georgia 30912, USA


• (1990-1994) PhD Biochemistry M.L. Sukhadia University, Udaipur, India
• (1986-1988) MS (Zoology) M.L. Sukhadia University, Udaipur, India
• (1982-1986) BS (Biology) Rajasthan University, Jaipur, India


• (2014-2014) Post Doctoral Research Fellow, Dr Nita Maihle’s Lab at Division of Molecular Oncology and Biomarkers, Cancer Center, Medical College of Georgia (MCG), Georgia Regents University (GRU), Augusta, GA
• (2014-2014) Post Doctoral Research Fellow, Dr Betty Pace’s Lab at Division of Hematology and Oncology, Department of Pediatrics, Medical College of Georgia (MCG), Georgia Regents University (GRU), Augusta, GA
• (2012-2013) Post Doctoral Research Fellow, Dr Jeff Mumm’s Lab at Department of Cell Biology and Anatomy, Medical College of Georgia (MCG), GHSU, Augusta, GA
• (2012-2012) Post Doctoral Research Associate, Dr Arup Neogi’s Lab at University of North Texas, Denton, TX
• (2007-2012) Post Doctoral Research Associate, Dr Pudur Jagadeeswarn’s Lab at University of North Texas, Denton, TX

Fatima Samad, MD

Advanced Cardiovascular Imaging Fellow
Aurora Health Care- St. Luke’s Medical Center
2900 W Oklahoma Ave
Milwaukee, WI 53215


• (2016-2017): Advanced Cardiac Imaging Fellow, Aurora Health Care– St Luke’s Medical Center, Milwaukee, WI, USA
• (2015-2016): Chief Academic Fellow, Cardiology, Rutgers University–New Jersey Medical School, Newark, NJ, USA
• (2013-2016): Cardiology Fellowship, Rutgers University- New Jersey Medical School, Newark, NJ, USA
• (2012-2013): Assistant Chief Resident, Internal Medicine Residency, New Jersey Medical School, Newark, NJ, USA
• (2010-2013): Internal Medicine Residency, UMDNJ- New Jersey Medical School, Newark, NJ, USA
• (2008-2010): Self Study
• (2003-2008): M.B.B.S/MD- Aga Khan University Medical College, Pakistan


Henry Pleass, MD

Department of Surgery
Westmead Clinical School
University of Sydney
Sydney, NSW, Australia

Professor Henry Pleass studied medicine as an undergraduate at the University of Newcastle Upon-Tyne, England and trained in general and transplantation surgery in the North East of England, Edinburgh Scotland and Sydney Australia. He is Professor of Surgery at Westmead Clinical School, University of Sydney. He is the surgical head of The Australian National Pancreas Transplant Programme based at Westmead, Sydney. In addition he is a VMO surgeon at Westmead Private Hospital and a VMO liver transplant surgeon at Royal Prince Alfred Hospital.

Scott Thomas, PhD

Staff Scientist
Department of Medicine
Division of Hematology and Oncology
Helen Diller Family Cancer Center
University of California
1450 3rd Street, HD 250
San Francisco, California 94158, USA

Dr. Thomas studied Cell Division as a Doctoral candidate with Professor Kenneth Kaplan at the University of California Davis and as a Postdoctoral Fellow he received training in translational oncology with Dr. Pamela Munster at the University of California San Francisco. Dr. Thomas is currently a Staff Scientist in the Department of Medicine at UCSFs Helen Diller Family Comprehensive Cancer Center.

Min-Fu Tsan, MD, PhD

Senior Research Scientist
Mc GuireResearch Institute, Inc.
Richmond, Virginia, USA

Dr. Tsan received his MD degree from the National Taiwan University Medical College in 1967 and a PhD degree in Physiology from the Harvard Medical School in 1971. He completed his training in medicine and hematology at the Johns Hopkins University School of Medicine in 1975. He taught medicine, hematology and nuclear medicine at Johns Hopkins from 1975-1982 and was promoted to the rank of Associate Professor of Medicine, Radiology and Environmental Health Sciences. During his tenure at Hopkins, he was the recipient of a Research Career Development Award (RCDA) from the National Institute of Allergy and Infectious Diseases. Between 1982 and 2000, he was the Associate Chief of Staff for Research and Development at the Stratton VA Medical Center in Albany, NY and Professor of Medicine and Physiology at the Albany Medical College. From 2000 until his retirement in January 2014, he was at the Office of Research Oversight (2000-2009, Regional Director, Mid-Atlantic Regional Office; 2009-2014, Deputy Chief Officer, Senior Executive Service; 2002-2006, Professor of Medicine, Georgetown University School of Medicine). Currently, he is a Senior Research Scientist at the McGuire Research Institute, Richmond, VA. Dr. Tsan is board certified by the American Board of Internal Medicine, the Subspecialty Board of Hematology, and the American Board of Nuclear Medicine. He has over 160 publications in peer-reviewed scientific journals.

Naved Iqbal, PhD

Department of Psychology
Head of the Department
Jamia Millia Islamia
New Delhi, Delhi 25, India

Alexios Strimpakos, MD, MRCP, PhD

Department of Medical Oncology
Athens Euro Clinic
7-9 Athanasiadou Street, Athens 115 21, Greece

Dr. Strimpakos studied Medicine as an undergraduate at the University of Patras, Greece and then General Medicine at Nottingham, UK and Medical Oncology at the Royal Marsden Hospital, UK. He developed special interest in Gastrointestinal and Thoracic Tumors and completed his PhD thesis in biomarkers in lung cancer at the University Of Athens. He has published several original and review articles mainly in gastrointestinal and lung cancers. He is currently a Director in the department of Medical Oncology at the Euro clinic Athens Hospital, Greece.

Ferenc Bánhidy, MD, MBBS

Deputy Head
Department of Obstetrics-Gynecology
Faculty of Medicine
Semmelweis University
Üllői út 78a, Budapest 1082, Hungary


• (1986) Medical doctor, General Medicine, Semmelweis Medical University, Budapest, Hungary
• (1990) Board exam of Obstetrics-Gynecology, Semmelweis University, Budapest, Hungary
• (1997) Board exam of Oncology, Clinical Oncology, Semmelweis University, Budapest, Hungary
• (2000) Board exam of Surgery, Surgery, Semmelweis University, Budapest, Hungary
• (2002) Postgraduate course on Medical Economy, Medical Economy University of Szeged, Szeged, Hungary
• (2006) Board exam of Clinical Pharmacology, Clinical Pharmacology, Semmelweis University, Budapest, Hungary


• (2015-Present) Vice-Rector for General Affairs, Semmelweis University
• (2013- Present) Professor, Deputy Head, Semmelweis Egyetem, ÁOK, II. sz. Szülészeti-Nőgyógyászati Klinika
• (2012-2013) Professor, Head of Department, Semmelweis Egyetem, ÁOK, II. sz. Szülészeti-Nőgyógyászati Klinika
• (1990-2006) Associate Professor, Semmelweis Egyetem, ÁOK, II. sz. Szülészeti-Nőgyógyászati Klinika
• (1986-1990 Trainee, Semmelweis Egyetem, ÁOK, II. sz. Szülészeti-Nőgyógyászati Klinika

Michele Baccarani, MD

Department of Hematology
University of Bologna
Bologna, Italy

Dr. Baccarani was trained in medicine, hematology, and oncology at the Universities of Bologna (1966-1979), Paris (1967), and Copenhagenn (1971). He became professor of Cancer Chemotherapy at the University of Chieti in 1979, then he was appointed Professor of Haematology at the Universities of Trieste (1980-1986), Udine (1987-2000), and Bologna (2001-2012), where he was the Head of the Department of Haematology and Oncology L. and A. Seràgnoli at the S. Orsola-Malpighi University Hospital, Bologna, until November 2012.

Qiang Shen, MD, PhD

Assistant Professor (Tenure-Track)
Department of Clinical Cancer Prevention
Division of Cancer Prevention and Population Sciences
The University of Texas MD Anderson Cancer Center
Houston, TX, USA

Dr. Shen received his medical education from Jiangxi Medical College and Kunming MedicalUniversity in 1981 and 1989, and practiced medicine in China til 1995, He obtained a PhD degree in Cell Biology from the University of Texas Medical Branch at Galveston in 2002. Then he completed a postdoctoral fellowship training at Baylor College of Medicine with Dr. Powel Brown in the areas of breast cancer biology and molecular cancer prevention from 2002 to 2006, and was promoted to Instructor at Baylor from 2006 to 2009. Dr. Shen joined The University of Texas MD Anderson Cancer Center in 2009 as a tenure-track Assistant Professor in the Department of Clinical Cancer Prevention. Dr. Shen studies transcription factors including AP-1 and STAT3, kinases, and other signal molecules regulating cellular proliferation, apoptosis, and glucose metabolism in the development and progression ofbreast and other cancers, using molecular, cellular, and transgenic animal model approaches. Dr. Shen has published more than 30 peer-reviewed research articles, and is a co-inventor of two patents.

Wilbert S. Aronow, MD

Division of Cardiology
New York Medical College
Valhalla, NY, USA

Dr. Aronow is a Professor of Medicine at New York Medical College/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 13 books and is author or co-author of 1,470 papers, 322 commentaries or Letters to the Editor, and 1028 abstracts and is presenter or co-presenter of 1,389 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the AGS (Founding Fellow of Western Section), and the GSA. He has been a Member of 119 editorial boards of medical journals, editor-in-chief of 1 journal, co-editor of 2 journals, deputy editor of 1 journal, executive editor of 3 journals, associate editor for 9 journals, and guest editor for 7 other medical journals. He has received each year from 2001-2015 an outstanding teacher and researcher award from the medical residents and from 2001-2015 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellors Research Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, 2013, and 2014, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012. He has been a Member of 4 national guidelines committees including being a co-author of the 2010 AMDA guidelines for heart failure, co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a co-author of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and is currently a Member of the 2016 ACC/AHA/AAPAABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the management of patients with hypertension. He was a Co-author of a 2015 position paper from the International Lipid Expert Forum. He was a Consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis. He is currently a member of the Board of Directors of the ASPC and a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee.

Robert John Amato, DO

Professor and Division Director
Department of Internal Medicine and Oncology
The University of Texas Medical School
Houston, TX 77030, USA

Dr. Amato is the Director and a Professor of the Division of Oncology at the University of Texas Health Science Center at Houston and Director of the University of Texas Memorial Hermann Cancer Center. He obtained his Doctor of Osteopathic Medicine from the University of North Texas before becoming a fellow in Medical Oncology at MD Anderson Cancer Center.
Dr. Amato is one of the world’s leading experts in the treatment of genitourinary cancer. Early in his career, his research helped make testicular cancer a highly treatable disease. His current research focuses on molecular-targeted therapeutics to halt the progression of metastatic kidney and prostate cancers, the further development of immunotherapies with a primary focus on vaccine and immune therapy, and determining how elements from his current studies may be used in the treatment of bladder and testicular cancer.

Ravindra Kolhe, MD, PhD

Assistant Professor
Department of Pathology
Medical Director of Cytogenetics Laboratory
Laboratory Director of Georgia Esoteric & Molecular Labs
Medical College of Georgia at Augusta University
Augusta, GA, USA

Dr. Kolhe is an Assistant Professor in the Department of Pathology at the Georgia Regents University, Augusta GA. He is the CLIA laboratory director for the Georgia Esoteric and Molecular Labs and also serves as the Medical Director for the Cytogenetics Laboratory. He is a physician-scientist with expertise in basic mechanisms of tumor immunology, including tolerogenic DCs, Tregs, and the indoleamine 2,3-dioxygenase pathway. His work also lead to identification of mir-21 as a biomarker for early diagnosis of liver cancer. His laboratory is elucidating molecular mechanisms of acquired tolerance and immune suppression in tumor-bearing hosts, with a focus on the role of IDO-expressing DCs and IDO-activated Tregs in cancer. He haspublished numerous original research papers in leading journals, and presented his work at many national and international scientific meetings. He also serves on the editorial boards for journals in his field as well as acting as a reviewer of publications submitted to several scientific and clinical research journals.

Jichuan Wang, PhD

Children’s National Health System
Epidemiology and Biostatistics
The George Washington University School Medicine
Washington, DC 20010, USA

Dr. Wang is a Senior Biostatistician in the Center for Translational Science, Children’s National Health System, and Professor Of Epidemiology and Biostatistics, the George Washington University School of Medicine. He has been working in the field of public health studies for over two decades and has collaborated on numerous NIH and other federally funded projects. He has authored/co-authored over 100 peer-reviewed journal articles. He has written three statistics books.

Visit him at